PHLDB2 and head and neck squamous cell carcinoma: To assess the prognostic value of PHLDB2 expression in HNSCC, we conducted a Kaplan–Meier analysis and surprisingly found that patients with elevated PHLDB2 expression levels experienced poorer outcomes (Figure 1N).